Skip to main content
Log in

Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Serum thyrotropin (TSH) is a well-established growth factor for thyroid nodules and suppression of TSH concentrations by administering exogenous thyroxine may interfere with the growth of established nodules as well as the formation of new thyroid nodules. The aim of this study was to investigate whether serum TSH at presentation is a predictor of thyroid malignancy in patients with thyroid nodules.

Methods

A total of 565 patients without overt thyroid dysfunction, who presented with palpable thyroid nodule(s) between 1988 and 2004 and underwent at least one fine-needle aspiration biopsy, were retrospectively evaluated.

Results

The final diagnostic outcome was established after surgery (n = 122) or after a minimum of 1-year clinical follow-up period. Higher rates of malignancy were observed in patients with serum TSH in the upper tertile of the normal range (= 0.026). Binary logistic regression analysis revealed significantly increased adjusted odds ratios for the diagnosis of malignancy in patients with serum TSH 1.5–4.0 mIU/l when compared to those with either TSH 0.4–0.8 mIU/l (= 0.005) or TSH 0.9–1.4 mIU/l (= 0.007).

Conclusions

The risk of malignancy in thyroid nodules increases in parallel with TSH concentrations within the normal range. TSH concentration at presentation is an independent predictor of thyroid malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Belfiore A, Giuffrida D, La Rosa GL, Ippolito O, Russo G, Fiumara A, Vigneri R, Filetti S (1989) High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol (Copenh) 121:197–202

    CAS  Google Scholar 

  • Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363–369

    Article  PubMed  CAS  Google Scholar 

  • Block MA, Dailey GE, Robb JA (1983) Thyroid nodules indeterminate by needle biopsy. Am J Surg 146:72–78

    Article  PubMed  CAS  Google Scholar 

  • Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA (2006) Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295–4301

    Article  PubMed  CAS  Google Scholar 

  • Carayon P, Thomas-Morvan C, Castanas E, Tubiana M (1980) Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity. J Clin Endocrinol Metab 51:915–920

    PubMed  CAS  Google Scholar 

  • Cardis E, Howe G, Ron E, Bebeshko V, Bogdanova T, Bouville A, Carr Z, Chumak V, Davis S, Demidchik Y, Drozdovitch V, Gentner N, Gudzenko N, Hatch M, Ivanov V, Jacob P, Kapitonova E, Kenigsberg Y, Kesminiene A, Kopecky KJ, Kryuchkov V, Loos A, Pinchera A, Reiners C, Repacholi M, Shibata Y, Shore RE, Thomas G, Tirmarche M, Yamashita S, Zvonova I (2006) Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 26:127–140

    Article  PubMed  Google Scholar 

  • Castro MR, Gharib H (2005) Continuing controversies in the management of thyroid nodules. Ann Intern Med 142:926–931

    PubMed  Google Scholar 

  • Chang TC, Kuo SH, Liaw KY, Chang CC, Chen FW (1988) Cell kinetics, DNA content and TSH receptor–adenylate cyclase system in differentiated thyroid cancer. Clin Endocrinol (Oxf) 29:477–484

    Article  CAS  Google Scholar 

  • Chow LS, Gharib H, Goellner JR, van Heerden JA (2001) Nondiagnostic thyroid fine-needle aspiration cytology: management dilemmas. Thyroid 11:1147–1151

    Article  PubMed  CAS  Google Scholar 

  • Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142

    PubMed  Google Scholar 

  • Ezzat S, Sarti DA, Cain DR, Braunstein GD (1994) Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838–1840

    Article  PubMed  CAS  Google Scholar 

  • Franklyn JA, Daykin J, Young J, Oates GD, Sheppard MC (1993) Fine needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules. BMJ 307:240–240

    PubMed  CAS  Google Scholar 

  • Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen PR, Marqusee E, Alexander EK (2006) Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 91:3411–3417

    Article  PubMed  CAS  Google Scholar 

  • Garcia-Mayor RV, Perez Mendez LF, Paramo C, Luna CR, Rego IA, Regal M, Sierra JM, Fluiters E (1997) Fine-needle aspiration biopsy of thyroid nodules: impact on clinical practice. J Endocrinol Invest 20:482–487

    PubMed  CAS  Google Scholar 

  • Gharib H, Goellner JR (1993) Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118:282–289

    PubMed  CAS  Google Scholar 

  • Gharib H, Goellner JR, Zinsmeister AR, Grant CS, Van Heerden JA (1984) Fine-needle aspiration biopsy of the thyroid: the problem of suspicious cytologic findings. Ann Intern Med 101:25–28

    PubMed  CAS  Google Scholar 

  • Goldberg RC, Lindsay S, Nichols CW, Chaikoff IL (1964) Induction of neoplasms in thyroid glands of rats by subtotal thyroidectomy and by the injection of one microcurie of I-131. Cancer Res 24:35–43

    PubMed  CAS  Google Scholar 

  • Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12:20–37

    Article  PubMed  Google Scholar 

  • Hegedus L (2001) Thyroid ultrasound. Endocrinol Metab Clin North Am 30:339–360

    Article  PubMed  CAS  Google Scholar 

  • Hegedus L (2004) Clinical practice: the thyroid nodule. N Engl J Med 351:1764–1771

    Article  PubMed  Google Scholar 

  • Hegedus L, Bonnema SJ, Bennedbaek FN (2003) Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102–132

    Article  PubMed  Google Scholar 

  • Kim WB, Han SM, Kim TY, Nam-Goong IS, Gong G, Lee HK, Hong SJ, Shong YK (2004) Ultrasonographic screening for detection of thyroid cancer in patients with Graves’ disease. Clin Endocrinol (Oxf) 60:719–725

    Article  Google Scholar 

  • Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L, Jorgensen T (2002) Risk factors for goiter and thyroid nodules. Thyroid 12:879–888

    Article  PubMed  Google Scholar 

  • Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA Cancer J Clin 48:6–29

    Article  PubMed  CAS  Google Scholar 

  • Mann K (1998) Evaluation of risk in autonomously functioning thyroid nodules. Exp Clin Endocrinol Diabetes 106 Suppl 4:23–26

    Article  Google Scholar 

  • Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES, Mandel SJ (2000) Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 133:696–700

    PubMed  CAS  Google Scholar 

  • McCall A, Jarosz H, Lawrence AM, Paloyan E (1986) The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery 100:1128–1132

    PubMed  CAS  Google Scholar 

  • McHenry C, Smith M, Lawrence AM, Jarosz H, Paloyan E (1988) Nodular thyroid disease in children and adolescents: a high incidence of carcinoma. Am Surg 54:444–447

    PubMed  CAS  Google Scholar 

  • Morganti S, Ceda GP, Saccani M, Milli B, Ugolotti D, Prampolini R, Maggio M, Valenti G, Ceresini G (2005) Thyroid disease in the elderly: sex-related differences in clinical expression. J Endocrinol Invest 28:101–104

    PubMed  CAS  Google Scholar 

  • Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803

    Article  PubMed  CAS  Google Scholar 

  • Papini E, Petrucci L, Guglielmi R, Panunzi C, Rinaldi R, Bacci V, Crescenzi A, Nardi F, Fabbrini R, Pacella CM (1998) Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83:780–783

    Article  PubMed  CAS  Google Scholar 

  • Polyzos SA, Kita M, Avramidis A (2007) Thyroid nodules—stepwise diagnosis and management. Hormones (Athens) 6:101–119

    Google Scholar 

  • Pujol P, Daures JP, Nsakala N, Baldet L, Bringer J, Jaffiol C (1996) Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 81:4318–4323

    Article  PubMed  CAS  Google Scholar 

  • Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, Schumm-Draeger PM (2004) Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 14:926–932

    Article  PubMed  Google Scholar 

  • Ross DS (2006) Editorial: predicting thyroid malignancy. J Clin Endocrinol Metab 91:4253–4255

    Article  PubMed  CAS  Google Scholar 

  • Schneider AB, Bekerman C, Leland J, Rosengarten J, Hyun H, Collins B, Shore-Freedman E, Gierlowski TC (1997) Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab 82:4020–4027

    Article  PubMed  CAS  Google Scholar 

  • Tollin SR, Mery GM, Jelveh N, Fallon EF, Mikhail M, Blumenfeld W, Perlmutter S (2000) The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid 10:235–241

    PubMed  CAS  Google Scholar 

  • Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493

    Article  CAS  Google Scholar 

  • Tuttle RM, Lemar H, Burch HB (1998) Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 8:377–383

    Article  PubMed  CAS  Google Scholar 

  • Vander JB, Gaston EA, Dawber TR (1968) The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69:537–540

    PubMed  CAS  Google Scholar 

  • Werk EE, Vernon BM, Gonzalez JJ, Ungaro PC, McCoy RC (1984) Cancer in thyroid nodules. A community hospital survey. Arch Intern Med 144:474–476

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stergios A. Polyzos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Polyzos, S.A., Κita, M., Efstathiadou, Z. et al. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol 134, 953–960 (2008). https://doi.org/10.1007/s00432-008-0373-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-008-0373-7

Keywords

Navigation